| Literature DB >> 26943000 |
Laurel M Schunselaar1, Josine M M F Quispel-Janssen2, Jacques J C Neefjes1, Paul Baas2.
Abstract
Malignant pleural mesothelioma is an aggressive fatal malignancy with a prognosis that has not significantly improved in the last decades. This review summarizes the current state of treatment and the various attempts that are made to improve overall survival for patients with malignant pleural mesothelioma. It also discusses technologies and protocols to test new and hopefully more effective compounds in a more individualized manner. These developments are expected to improve the prognosis for this group of patients.Entities:
Keywords: Chemotherapy; immunotherapy; mesothelioma; mouse models; pre-clinical models; primary tumor culture; targeted agent; treatment
Mesh：
Substances：
Year: 2016 PMID： 26943000 DOI： 10.1586/14737140.2016.1162100
Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN： 1473-7140 Impact factor: 4.512